Sinopharm Group Co. Ltd. SHTDY
10.69 USD +0.25 (+2.39%)
Nov 4, 2026, 3:11 PM EST
10.69 Day range 10.69
9.00 52-week range 14.87
- YTD
- -13.79%
- 1 year
- -13.72%
- Market cap
- 6.67B
- EPS (ttm)
- 1.62
- P/E ratio
- 6.60
- YTD return
- -13.79%
- 1-year return
- -13.72%
- Volume
- 819
- Avg volume
- 167.22K
- Open
- 10.69
- Previous close
- 10.44
- Day's range
- 10.69 – 10.69
- 52-week range
- 9.00 – 14.87
2Y -1.84 (-14.68%)
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Apr 23, 2026 | Dec 31, 2025 | — | 0.829 | — | — |
| Aug 28, 2025 | Jun 30, 2025 | — | 0.774 | — | — |
| Aug 23, 2024 | Jun 30, 2024 | — | 0.1007 | — | — |
News
Sinopharm Group (OTCMKTS:SHTDY) and Pediatrix Medical Group (NYSE:MD) Financial Survey 
Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities 
Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary 
Lakeside Strengthens Market Position in China's Pharmaceutical Logistics with Key Sinopharm(Hubei) Contracts 
Jim Cramer Says China's Vaccines 'Don't Work' But Xi Won't Admit It 
Pandemic Accelerates China's Drive Into mRNA Treatments 
Week In Review: WHO Close To Approving Global Use For 2 China COVID-19 Vaccines 
Diversifying Into Top-Ranked Sinopharm 
Week In Review: Sinopharm Transfers $4.6 Billion In Assets Including Two COVID-19 Vaccines 
Week In Review: Eluminex Raises $50 Million For Ophthalmology Drugs
Your note
Sign in to keep a note on SHTDY — it syncs with the Stock Master app.